Sanchez-de la Rosa, Rainel; Sabater, Eliazar; Casado, … - In: Health Economics Review 3 (2013) 13, pp. 1-5
Background: Fingolimod is an innovative drug with a significant budget impact in the treatment of MS in Spain. The aim … of this study was to calculate the direct cost comparison of glatiramer acetate and fingolimod for the treatment of … patients with relapsing-remitting multiple sclerosis (RRMS) in Spain. Methods: A cost analysis model was developed to compare …